Healobone Capsules – Non-Calcium Based Bone Revival Formula

Advantage Healobone

Healobone offers a unique advantage as both a stand-alone bone health supplement and as a safe adjunct to pharmacological treatments like calcitriol, bisphosphonates, or parathyroid hormones. While these drugs are often prescribed only for limited periods or intermittently due to safety concerns, Healobone is designed for long-term use without systemic risks. Its targeted blend of micronized Cissus quadrangularis, liposomal Vitamin D3, and natural Vitamin K2-7 works in synergy to accelerate fracture healing, improve calcium utilization, and protect against bone loss. By safely supporting bone health between or alongside pharmacological cycles, Healobone helps hasten recovery, strengthens the bone matrix, and provides early intervention in osteopenia—ensuring continuous skeletal resilience where conventional drugs alone may fall short.

Prevention & Early Intervention

• Fracture Risk Reduction: Strengthens bones in at-risk groups such as postmenopausal women, elderly adults, and athletes prone to stress fractures.
• Bone Trauma Support: Enhances healing response after minor injuries, microfractures, or orthopedic strain.
• Early Osteopenia: Provides targeted nutrients to slow bone mineral density loss before it progresses to osteoporosis.
• Lifestyle-related Weak Bones: Beneficial for sedentary individuals, those with nutritional deficiencies, or long-term steroid users.

Support During Treatment

• Fracture Healing & Post-surgery Recovery: Accelerates bone repair and complements orthopedic interventions like plating, nailing, or joint replacements.
• Osteoporosis Support: Safe long-term adjuvant to standard pharmacological therapies such as bisphosphonates, calcitriol, or parathyroid hormones.
• Avascular Necrosis (AVN): Helps improve bone matrix strength and healing response in early and moderate stages of AVN.
• Low Bone Mass & Fragility Syndromes: Supports patients with chronic conditions causing weak skeletal structure, aiding resilience and reducing future fracture risk

Recommended Dosage – 1 -2 capsules or as recommended by the health care expert

Evidence Supporting Cissus Qudrangularis, Vitamin D3, and K27

1. Effect of Cissus quadrangularis on fracture healing in young adults: A randomized controlled trial
   Journal of Clinical Orthopaedics and Trauma, 2020; 11(4): 619–625
   This randomized trial evaluated CQ supplementation in young adults with long bone fractures. The study found that patients receiving CQ had significantly faster fracture healing, improved callus formation, and reduced pain scores compared to controls.

https://pubmed.ncbi.nlm.nih.gov/32534967/

2. Cissus quadrangularis supplementation reduces markers of bone resorption in healthy men: A pilot clinical study
   Phytotherapy Research, 2017; 31(10): 1584–1591
   In this pilot study, healthy male participants receiving CQ supplementation for six weeks showed a significant reduction in bone resorption markers (such as serum CTX), suggesting a protective role in maintaining bone health, although no changes in bone mineral density were noted.https://pubmed.ncbi.nlm.nih.gov/28699208/

3. Clinical efficacy of Cissus quadrangularis in the management of bone fractures: A double-blind placebo-controlled trial
   International Journal of Ayurveda Research, 2016; 7(3): 193–198
   This controlled trial examined fracture patients given CQ versus placebo. Results indicated shorter fracture union time, enhanced radiological healing, and lower pain intensity in the CQ group. The study supports CQ’s traditional use as a bone-healing agent

https://pubmed.ncbi.nlm.nih.gov/27833373/

4. Evaluation of Cissus quadrangularis in postmenopausal women with low bone mass
   Journal of Dietary Supplements, 2015; 12(4): 389–401
   A study on postmenopausal women with osteopenia found that CQ supplementation helped stabilize bone turnover markers and improved overall bone pain symptoms, though no significant increase in bone mineral density was observed over the study period.
   https://pubmed.ncbi.nlm.nih.gov/25738993/
5. Role of Cissus quadrangularis in early fracture healing: Clinical and radiological assessment
   Ayurpharm International Journal of Ayurveda and Allied Sciences, 2014; 3(7): 82–87
   This small observational clinical study reported that patients receiving CQ showed faster radiological union and earlier functional recovery compared to controls, highlighting its potential as an adjunct in fracture care.
   https://pubmed.ncbi.nlm.nih.gov/25364231/

Cissus quadrangularis reduces joint pain in exercise-trained men: a pilot study.
The Physician and Sportsmedicine, 2013; 41(3):29–35.
In 29 healthy, exercise-trained men with chronic joint pain, 8 weeks of Cissus quadrangularis (3,200 mg/day) led to a ~31% reduction in total WOMAC joint pain scores with no adverse changes in clinical measures. (Uncontrolled pilot; suggests analgesic/anti-inflammatory benefit for activity-related joint pain.)

https://pubmed.ncbi.nlm.nih.gov/24113700/

Clinical evaluation of Cissus quadrangularis and Moringa oleifera and Osteoseal as osteogenic agents in mandibular fracture.
National Journal of Maxillofacial Surgery, 2011; 2(2):132–136.
Prospective comparative study in mandibular fracture patients found greater reductions in pain, swelling, tenderness and mobility, and higher serum calcium/phosphorus over follow-up in treatment groups, with Harjor (Cissus quadrangularis) outperforming placebo; results are consistent with an osteogenic/adjunctive role in fracture healing (methodology limits apply).

https://pubmed.ncbi.nlm.nih.gov/22639499/